An international clinical trial involving Monash researchers – of more than 3600 patients in 74 hospitals – has shown that a traditional long course of antibiotics for bloodstream infection are not ...
Simon R. Schultz is Professor of Neurotechnology in the Department of Bioengineering at Imperial College London, and Director of the Imperial Centre of Excellence in Neurotechnology. He grew up in ...
Dr Shannon Faulkhead is a Koorie woman from Mildura and Head of First Peoples Research and Collections at the Museums Victoria Research Institute. She is responsible for the care of, and community ...
Professor Arnold Dix professionally focuses on truth and justice – science and law. He is a geologist, an engineer, and a lawyer, who is nationally and internationally known for being a tunnelling ...
As passionate scuba diver and industrial designer, Alex Goad has dedicated his career to merging innovative design with marine conservation. His journey began at Monash University, where he completed ...
Mr Mark McDougall is the Global Chief Information Officer for Computershare and the Global Chief Executive Officer for Computershare Communication Services. Mr McDougall graduated from Monash ...
The ‘next 1,000 days’ is a crucial time in the development of a child into adolescence and adulthood – it’s when they rapidly develop motor skills, become independent in their movement and physical ...
Melbourne researchers are helping expand options for people with high cholesterol that puts them at risk of heart attack or stroke, including world-first drugs for potentially deadly conditions.
The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its “calming agent” action in turning off the body’s inflammatory response and preventing chronic ...